Hüseyin Ulaş Pınar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hüseyin Ulaş Pınar has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
- Omer Karaca
Department of Anesthesiology and Reanimation, Private Anit Hospital, Konya, Turkey
4 shared publications - Rafi Dogan
Department of Anesthesiology and Reanimation, Baskent University Faculty of Medicine, Ankara, Turkey
3 shared publications - Ayşe Heves Karagöz
Department of Anesthesiology and Reanimation, Hacettepe University Faculty of Medicine, Ankara, Türkiye
2 shared publications - Hilal Ayoğlu
Department of Anesthesiology and Reanimation, Zonguldak Bulent Ecevit University, Faculty of Medicine, Zonguldak, Turkey
2 shared publications - Abdurrahman Tünay
Univ Hlth Sci Turkey, Istanbul Training & Res Hosp, Clin Anaesthesiol, Istanbul, Turkiye
1 shared publication - Ahmet Eroglu
Anesthesiology and Intensive Care Medicine Karadeniz Technical University Trabzon Turkey
1 shared publication
Latest Publications
- 22 June 2026
- Published by Academician Publishing
Günübirlik Anestezi ve Ameliyathane Dışı Anestezi Uygulamaları
- 22 June 2026
- Published by Academician Publishing
Günübirlik Anestezi ve Ameliyathane Dışı Anestezi Uygulamaları
- 22 June 2026
- Published by Academician Publishing
- p. 261-280
Analjezi Amaçlı Fasiyal Plan Blokları
- 10 June 2026
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 43 (7) , 637-638
Reconsidering the recommendation against self-reported metabolic equivalents of task in pre-operative assessment in light of emerging evidence
- 10 June 2026
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 43 (7) , 637-638
Reconsidering the recommendation against self-reported metabolic equivalents of task in pre-operative assessment in light of emerging evidence
- Open Access
- 22 November 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (1) , 11-16
Evaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study
COVID-19,intensive care,intensive care unit,pandemic,follow-up
- 22 November 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (1) , 11-16
Open AccessEvaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study
COVID-19,intensive care,intensive care unit,pandemic,follow-up
- Open Access
- 3 April 2021
- Published by Academician Publishing
- p. 135-146
Yoğun Bakımda Kronik Obstrüktif Akciğer Hastalığına Yaklaşım
- 3 April 2021
- Published by Academician Publishing
- p. 135-146
Open AccessYoğun Bakımda Kronik Obstrüktif Akciğer Hastalığına Yaklaşım
- Open Access
- 1 January 2019
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 49 (6) , 1693-1700
The effect of pregabalin on the tourniquet induced ischemia-reperfusion injury. A Prospective Randomized Study
Background/aim: The aim of this study was to investigate the efficacy of pregabalin on ischemia-reperfusion injuries. Materials and methods: Fifty-four patients were randomly assigned into 2 groups. A 150-mg tablet of pregabalin was given the night before and then 1 h before the operation for patients in Group P (pregabalin group, n = 27). A placebo was given to patients in Group C (control group, n = 27) at the same times. After combined spinal-epidural anesthesia was performed, venous blood samples were taken before tourniquet inflation (t(1)), just before tourniquet deflation (t(2)), and 20 min after tourniquet deflation (t(3)) for the analysis of total antioxidant status (TAS), total oxidant status (TOS), catalase (CAT), and ischemia-modified albumin (IMA). Results: There was no significant difference in TAS levels between the groups for the t(3) period. However, the TAS in Group P was significantly higher in the t(3) period than the t(2) period (mean +/- SD, 0.46 +/- 0.1 vs. 0.38 +/- 0.2 mmol of Trolox equivalent/L, respectively; P < 0.05). The CAT level in the C period was significantly higher in Group P than Group C (mean +/- SD, 53.04 +/- 32.1 vs. 35.46 +/- 17.2 mu mol/formaldehyde, respectively; P < 0.05). In the t(3) period, the TOS was significantly lower in Group P than Group C (mean +/- SD, 11.97 +/- 5 vs. 18.29 +/- 9.9 pg/mL, respectively; P < 0.05). The TOS in Group P was significantly lower in the t(3) period than the t(2) period (mean +/- SD, 11.97 +/- 5 vs. 18.98 +/- 10.7 pg/mL, respectively; P < 0.0001). Conclusion: Pregabalin has no marked antioxidant activity, but it contributes to the antioxidant defense system of an organism.
- 1 January 2019
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 49 (6) , 1693-1700
Open AccessThe effect of pregabalin on the tourniquet induced ischemia-reperfusion injury. A Prospective Randomized Study
Background/aim: The aim of this study was to investigate the efficacy of pregabalin on ischemia-reperfusion injuries. Materials and methods: Fifty-four patients were randomly assigned into 2 groups. A 150-mg tablet of pregabalin was given the night before and then 1 h before the operation for patients in Group P (pregabalin group, n = 27). A placebo was given to patients in Group C (control group, n = 27) at the same times. After combined spinal-epidural anesthesia was performed, venous blood samples were taken before tourniquet inflation (t(1)), just before tourniquet deflation (t(2)), and 20 min after tourniquet deflation (t(3)) for the analysis of total antioxidant status (TAS), total oxidant status (TOS), catalase (CAT), and ischemia-modified albumin (IMA). Results: There was no significant difference in TAS levels between the groups for the t(3) period. However, the TAS in Group P was significantly higher in the t(3) period than the t(2) period (mean +/- SD, 0.46 +/- 0.1 vs. 0.38 +/- 0.2 mmol of Trolox equivalent/L, respectively; P < 0.05). The CAT level in the C period was significantly higher in Group P than Group C (mean +/- SD, 53.04 +/- 32.1 vs. 35.46 +/- 17.2 mu mol/formaldehyde, respectively; P < 0.05). In the t(3) period, the TOS was significantly lower in Group P than Group C (mean +/- SD, 11.97 +/- 5 vs. 18.29 +/- 9.9 pg/mL, respectively; P < 0.05). The TOS in Group P was significantly lower in the t(3) period than the t(2) period (mean +/- SD, 11.97 +/- 5 vs. 18.98 +/- 10.7 pg/mL, respectively; P < 0.0001). Conclusion: Pregabalin has no marked antioxidant activity, but it contributes to the antioxidant defense system of an organism.
- 1 January 2019
- Published by Baycinar Tibbi Yayincilik in Ağrı - The Journal of The Turkish Society of Algology
- Vol. 31 (3) , 161
Tremor on the same extremity after axillary brachial plexus block
- 1 January 2019
- Published by Baycinar Tibbi Yayincilik in Ağrı - The Journal of The Turkish Society of Algology
- Vol. 31 (3) , 161
Tremor on the same extremity after axillary brachial plexus block